I assume due diligence applies to the agreement between MSB and Celgene. If so, can anyone please advise when Celgene would have gained access to MSB info as in trial results, when that access will cease and to which trials access would apply?
Thanks if anyone can help
Further thoughts on Celgene deal, page-48
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 18753 | 3 |
View Market Depth
| Last trade - 09.43am 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable